Location History:
- Pomezia, IT (2006)
- Petriano, IT (2007 - 2019)
Company Filing History:
9 out of 15,471 
9 out of 20 
6 out of 6 
Years Active: 2006-2019
Title: The Innovative Contributions of Giorgio Tarzia
Introduction
Giorgio Tarzia, an esteemed inventor based in Petriano, Italy, has made significant contributions to the field of pharmaceutical sciences. With a remarkable portfolio that includes 12 patents, Tarzia has focused his research on the mechanisms of pain and inflammation, exploring innovative compounds to aid in the treatment of various medical conditions.
Latest Patents
Among his latest patents, Tarzia developed compositions and methods aimed at inhibiting N-acylethanolamine-hydrolyzing acid amidase (NAAA). This inhibition is crucial in increasing the concentration of palmitoylethanolamide (PEA), a substrate whose reduced levels are associated with conditions like inflammation. His work includes specialized amide derivatives that serve as effective NAAA inhibitors, presenting promising therapeutic agents for alleviating pain, treating inflammatory diseases, and promoting overall health.
Career Highlights
Tarzia’s career has been marked by his tenure at notable research institutions, including the University of California and Università degli Studi di Parma. His innovative spirit and determination have led to advancements in understanding the role of fatty acid ethanolamides in various disorders. These experiences have significantly shaped his approach to invention and research.
Collaborations
Collaboration has played a crucial role in Tarzia’s achievements. He has worked alongside distinguished colleagues such as Marco Mor and Daniele Piomelli, further enhancing the breadth of knowledge and expertise within his research endeavors. These partnerships have facilitated the exploration of complex scientific questions and contributed to the success of his patents.
Conclusion
Giorgio Tarzia stands out as a prolific inventor whose work is intricately linked to the advancement of medical science. His patented innovations targeting N-acylethanolamine-hydrolyzing acid amidase reveal his commitment to improving therapies for inflammatory conditions. Through his collaborations and extensive research, Tarzia continues to pave the way for future breakthroughs in pharmaceuticals.